InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Quinn William P., Chief Financial Officer. Officer active across 1 companies, notably Bolt Biotherapeutics, Inc.. Aggregated, 2 filings have been recorded. Total volume traded: €34k. The latest transaction was disclosed on 4 June 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€16,7561,221 shares@ €13.7229100.0% of flow
Common Stock
SEC:0000899243-21-047518·
Ideal exit: 1 Mar 2022 (T+270)
€16,7561,221 shares@ €13.72290.16% mcap50.0% of flow
Common Stock
SEC:0000899243-21-047518:0·
Ideal exit: 1 Mar 2022 (T+270)
2 of 2 declarations
About Quinn William P.
William P. Quinn is the Chief Financial Officer of Bolt Biotherapeutics, Inc. He is responsible for the financial management of the company, which focuses on developing immuno-oncology therapies.
